Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
buyouts
MedTech
Agiliti to go private in $2.5B buyout deal
Less than three years after debuting on the New York Stock Exchange in an initial public offering, Agiliti is leaving the public market.
Andrea Park
Feb 27, 2024 11:19am
Permira takes CRO Ergomed private in £703M buyout deal
Sep 7, 2023 5:00am
Quince adopts 'poison pill' to fend off buyout, stock purchases
Apr 6, 2023 8:24am
Ginkgo scoops up AAV gene therapy capsid specialist StrideBio
Apr 5, 2023 7:00am
Medtronic ties up first closing of $50M Acutus asset buy
Jul 1, 2022 12:00pm
Novartis pens buyout pact with fellow Swiss native Cellerys
Jun 1, 2021 7:35am
